14-day Premium Trial Subscription Try For FreeTry Free

iShares Nasdaq Biotechnology Index Fund ETF Price (Quote)

$133.28
+0.260 (+0.195%)
At Close: May 07, 2024

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 IBB stock ended at $133.28. This is 0.195% more than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 0.81% from a day low at $132.47 to a day high of $133.54.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical iShares Nasdaq Biotechnology Index Fund prices

Date Open High Low Close Volume
Mar 16, 2016 $83.82 $85.17 $82.25 $83.40 9 685 200
Mar 15, 2016 $85.99 $86.49 $83.48 $83.82 7 502 100
Mar 14, 2016 $87.26 $87.89 $86.89 $87.15 2 838 600
Mar 11, 2016 $85.98 $87.39 $85.47 $87.31 5 350 800
Mar 10, 2016 $85.91 $87.40 $84.13 $85.03 6 606 900
Mar 09, 2016 $87.10 $87.27 $84.55 $85.71 8 790 300
Mar 08, 2016 $89.49 $89.65 $86.48 $86.71 5 044 200
Mar 07, 2016 $87.23 $90.69 $86.97 $89.92 6 287 700
Mar 04, 2016 $88.29 $89.24 $87.13 $87.71 7 159 200
Mar 03, 2016 $89.43 $89.47 $87.64 $88.08 3 186 900
Mar 02, 2016 $88.41 $89.93 $88.02 $89.37 6 763 500
Mar 01, 2016 $85.53 $88.44 $84.58 $88.42 8 277 000
Feb 29, 2016 $87.11 $87.20 $84.70 $84.70 5 165 700
Feb 26, 2016 $87.25 $87.91 $86.55 $87.16 5 088 300
Feb 25, 2016 $86.67 $87.71 $85.55 $86.44 3 507 600
Feb 24, 2016 $84.69 $86.42 $83.40 $86.26 6 380 400
Feb 23, 2016 $87.45 $88.29 $85.74 $85.81 4 089 600
Feb 22, 2016 $88.65 $88.79 $87.32 $87.87 3 958 200
Feb 19, 2016 $86.22 $87.59 $85.17 $87.28 5 487 900
Feb 18, 2016 $89.06 $89.20 $86.34 $86.47 6 281 100
Feb 17, 2016 $87.84 $88.87 $86.23 $88.77 7 642 200
Feb 16, 2016 $85.11 $86.25 $84.80 $86.24 7 767 600
Feb 12, 2016 $82.50 $83.79 $80.54 $83.73 7 247 100
Feb 11, 2016 $80.98 $82.08 $80.18 $81.35 8 372 700
Feb 10, 2016 $83.15 $85.86 $82.88 $83.31 6 444 300
Click to get the best stock tips daily for free!

About iShares Nasdaq Biotechnology Index Fund

The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of NASDAQ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representin... IBB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT